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Purpose: High-quality, wide-field retinal imaging is a valuable method for screening
preventable, vision-threatening diseases of the retina. Smartphone-based retinal
cameras hold promise for increasing access to retinal imaging, but variable image
quality and restricted field of view can limit their utility. We developed and clinically
tested a smartphone-based system that addresses these challenges with automation-
assisted imaging.
Methods: The system was designed to improve smartphone retinal imaging by
combining automated fixation guidance, photomontage, and multicolored illumina-
tion with optimized optics, user-tested ergonomics, and touch-screen interface.
System performance was evaluated from images of ophthalmic patients taken by
nonophthalmic personnel. Two masked ophthalmologists evaluated images for
abnormalities and disease severity.
Results: The system automatically generated 1008 retinal photomontages from five
overlapping images in under 1 minute at full resolution (52.3 pixels per retinal degree)
fully on-phone, revealing numerous retinal abnormalities. Feasibility of the system for
diabetic retinopathy (DR) screening using the retinal photomontages was performed
in 71 diabetics by masked graders. DR grade matched perfectly with dilated clinical
examination in 55.1% of eyes and within 1 severity level for 85.2% of eyes. For referral-
warranted DR, average sensitivity was 93.3% and specificity 56.8%.
Conclusions: Automation-assisted imaging produced high-quality, wide-field retinal
images that demonstrate the potential of smartphone-based retinal cameras to be
used for retinal disease screening.
Translational Relevance: Enhancement of smartphone-based retinal imaging
through automation and software intelligence holds great promise for increasing
the accessibility of retinal screening.
Introduction
Retinal photography is used extensively to assist
with diagnosis and monitoring of retinal diseases.
However, access to traditional tabletop retinal cam-
eras is limited by their high-cost, bulky design and
need for skilled operators. Conventional imaging
approaches also require patient cooperation with
stabilized, upright head positioning, which can be
difficult among sick, wheelchair-bound, and immobi-
lized patients, as well as children.1 Handheld oph-
thalmoscopes with digital image capture offer an
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alternative. Recently, smartphone-based retinal im-
aging approaches have been described that leverage
the phone for its portability, high-resolution camera,
and wireless data transfer capabilities to capture
diagnostic images for real-time or remote anterior2 or
posterior segment3–12 evaluation at a fraction of the
cost of traditional instruments.8–10,12 These investiga-
tions nicely demonstrate the growing potential for
smartphone imaging to expand the accessibility of
ophthalmic care and photographic screening of
vision-threatening diseases.
There is particularly great interest in the validation
and integration of smartphone-based retinal photog-
raphy in local community screening programs for
diseases, such as glaucoma and diabetic retinopathy
(DR),13–16 as well as in the emergency department and
inpatient settings where the fundus examination is
underperformed.17–19 DR is the most common
microvascular complication of diabetes and the
leading cause of vision loss in working-age adults
aged 20 to 74 in the United States, accounting for 12%
of new cases annually.20–23 The World Health
Organization estimates more than 346 million people
worldwide have diabetes and that 552 million people
will be affected by 2030.24 Physicians have effective
treatments for complications of DR, and it has been
shown that patients have better vision outcomes with
early detection and treatment.25–27 However, despite
well-accepted guidelines,28 nearly half of diabetic
adults in the United States do not receive recom-
mended annual screening for DR, and vulnerable
populations with less access to specialty medical care
have an estimated screening rate of between 10% and
20% per year.29 Ophthalmologists recognize that
telehealth screening of DR via retinal photography
in the primary care setting, with remote ophthalmol-
ogist consultation,30 is a mechanism to improve access
and thereby improve outcomes in a cost-effective
manner.31,32 A remaining challenge is how to increase
access to such retinal photography.
The gold-standard photographic screening tech-
nique for DR is seven-field, 308 mydriatic tabletop
retinal photography33 in which 14 images per eye
from seven standard fields comprising the posterior
908 of the retina are evaluated to determine the risk of
vision loss and retinopathy progression. Subsequent
studies have demonstrated that three-field, 458 non-
mydriatic fundus photography was effective in
grading DR to determine referral-warranted disease,
whereas a single 458 photograph was insufficient to
accurately grade DR.34–36 Importantly, imaging by
nonexpert operators may affect image quality and is
an important consideration for community-based
screening efforts.37,38 Several studies have investi-
gated smartphone-based screening of DR4,16,39 and
reported sensitivities of 80% or more with high
specificities, as recommended by the British Diabetic
Association for new imaging devices in population-
based screening.40 However, other investigators have
found insufficient sensitivities of below 60% for
detecting DR37 suggesting smartphone imaging is
not universally reliable. In light of this, smartphone-
based retinal imaging has continued to undergo
validation against more traditional photographic
methods.37,41–43
We previously reported on the development of the
Ocular CellScope, a handheld, smartphone-integrated
imaging device capable of capturing high-quality,
wide-field images of the retina.3 From extensive field-
testing with that device, we identified several chal-
lenges facing the performance and use of that device
in particular and smartphone-based retinal photogra-
phy in general. First, surveying wide regions of the
retina with a handheld device is technically challeng-
ing and requires extensive operator experience to
comprehensively image the peripheral retina. Second,
sustained levels of bright white-light illumination for
high-resolution images of the retina can be uncom-
fortable for patients, resulting in poor image locali-
zation caused by gaze shifts and decreased image
quality from motion artifacts. Third, smartphone
imaging approaches have typically required two-
handed operation and been asymmetric, with differ-
ent orientation for the right and left eye, increasing
operator instability and motion. Fourth, the lack of
streamlined data management for acquiring, viewing,
and storing images slows workflow and increased
examination time.
Here, we demonstrate a retinal imaging system,
CellScope Retina, that addresses these issues by
incorporating automation to improve image quality
and reliability. We describe the application of
CellScope Retina in feasibility studies in inpatient
and outpatient settings, where images of various
retinal pathologies, including DR, were captured. The
1008 field was chosen to ensure that a larger portion
of the retina is imaged with CellScope Retina than the
gold-standard Early Treatment Diabetic Retinopathy
Study (ETDRS) screening technique, which evaluates
the posterior 908 using seven individual 308 field
images. Additionally, CellScope Retina images have a
resolution of 52.3 pixels per retinal degree, surpassing
the minimum resolution requirement of 30 pixels per
degree described by the National Health Service for
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diabetic retinopathy.44 To our knowledge, CellScope
Retina is the first demonstration of an automated
smartphone-based system capable of imaging, stitch-
ing, and reviewing a wide-field retinal montage in a




The CellScope Retina weighs approximately 310 g
and consists of a smartphone and three-dimensional
(3D)-printed plastic housing containing optics for
illuminating and imaging the retina in conjunction
with the camera of a smartphone (Fig. 1A). A
polarizing wire grid beam splitter (Moxtek
HCPBF02A, Orem, UT) is used to illuminate the
retina with polarized light and minimize unwanted
reflections as previously described.3 A custom printed
circuit board (PCB) provides illumination with a
single white light-emitting diode (LED; Lumileds
Luxeon LXML-PWN2, Brantford, Ontario, Canada)
at the center and a ring of radius 3.15 mm with three
deep red (655-nm peak wavelength) LEDs (Lumileds
Luxeon LXM3-PD01, San Jose, CA). An aspheric
condenser lens (Thorlabs ACL12708U-A, Newton,
NJ) transmits light from the LEDs to a diffuser
(Thorlabs ED1-C50), through a polarizer, an annular
mask with 8-mm inner diameter and 15-mm outer
diameter, and a 50-mm focal length condenser lens
(Thorlabs LA1171-A). The illumination light is
reflected by a beam splitter and passes through a
54-diopter ophthalmic lens (Ocular Instruments OI54-
A, Bellevue, WA) to form an annulus with a 4.8-mm
inner diameter and 9.6-mm outer diameter at the
surface of the cornea. The illumination light defocuses
and uniformly illuminates the retina, from which it is
scattered with accompanying depolarization. Light
from the eye is collected and transmitted through a
second polarizer (Edmund Optics 85919, Barrington,
NJ), thereby preferentially blocking reflected (and
orthogonally polarized) illumination light. An achro-
Figure 1. CellScope Retina schematic and workflow. (A)
Schematic of the optical system. Light from LEDs is directed
through a mask and forms an annulus that passes through the
peripheral cornea and focuses through the pupil. In propagating
through the eye the light becomes defocused, providing even
illumination at the retina. Polarization filters minimize unwanted
reflections from anterior ocular surfaces, enabling the smartphone
to capture a clear image of the retina. (B) The compact optical
system and custom-control electronics fit inside a handheld
enclosure. (C) Red LED illumination of 655-nm peak emission is
used for focusing on the retina, which is within the spectral range
of the iPhone camera but outside the peak photopic response of
the eye. (D) A white LED with a broad emission spectrum is flashed
for recording images of the retina. LED spectra in (C) and (D) are
 
from respective datasheets; photopic response is from CIE 1931
standard; phone response is approximate for a CMOS phone
sensor. (E) Smartphone user interface enables (1) patient data
capture, (2) preview during focus/alignment with swipe gestures
adjusting camera settings, and (3) exam data review with pinch
and swipe gestures for browsing stitched image montage. (F)
Photos can be uploaded directly from the smartphone to a cloud
database allowing remote diagnosis with a web interface.
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matic lens with a focal length of 20 mm (Edmund
Optics 47661) relays the signal to the smartphone
camera module.
The device is powered by a rechargeable lithium
polymer battery and includes a compact, custom-
printed circuit board containing a microcontroller
module (Arduino Micro, Somerville, MA), Bluetooth
transceiver (RedBearLabs BLEMini, Hong Kong,
China), two buck/boost controlled-current LED
drivers, battery management controller, power sup-
ply, and several status indicator LEDs. The battery,
electronics, and illumination optics are miniaturized
and arranged in linear fashion along the optical axis
to fit within the handle of the device (Fig. 1B). An
external organic LED display (4D Systems lOLED-
128-G2, Minchinbury, Australia) provides a fixation
target for the contralateral eye (Fig. 1B). This external
display attaches to either side of the CellScope Retina
housing using magnets, allowing symmetrical use
while imaging either eye. Spring-loaded gold pins
provide electrical contact for power and communica-
tion to the microcontroller. To conserve in-the-field
battery life, the system automatically shuts off after 5
minutes of inactivity. Under normal daily use, the
device runs for more than a week on a single charge
and, like the smartphone, can be recharged with a
standard USB cable.
Light hazards were assessed based on the ISO
15004-2:2007 standard, and informed by Sliney et
al.45 In regard to the standard, the red (see Figs. 1C
and 1D for LED spectra) focusing LEDs are a
continuous source while in use (CW; though in
practice not continuously illuminated), while the
white LED flash is a pulsed source. The red LEDs
produce 0.67 mW or less maximum at the cornea, and
the LEDs illuminate 0.1 cm2 or more of the cornea
and 1 cm2 or more of the retina, placing the red
illumination more than 1003 below the ISO 15004
§5.4 safety limits for Group 1 CW instruments. The
white LED flash produces 80-ms pulses with peak
powers of 19.4 mW (software limited to 8.1 mW in
use); this places the combined illumination safely
below the §5.4 safety limits for Group 1 Pulsed
instruments even for extremely high pulse counts:
assuming 250 flashes (a large overestimate of likely
use – a typical 5-image montage would require ~5
pulses) and flash rates of 5/second (again overesti-
mated; 1 per second is a likely maximum), the safety
factor is over 53 for §5.4.2.1.a, and over 203 for the
other limits. For completeness, we also compared the
white LED flash illumination with the §5.5.2 Group 2
Limits for Pulsed Instruments and the §5.5.1 Group 2
Limits for CW Instruments, and the device complies
with both. The radiant exposure guideline (§5.5.1.6.a)
falls at the equivalent of well over 1000 pulses.
Application and Software Design
A custom iPhone (Apple Inc., Cupertino, CA)
application (app) was developed which communi-
cates with the electronic hardware of CellScope
Retina via Bluetooth low-energy (BLE). To begin an
exam, the operator enters basic patient information
and then selects an eye for imaging. The app
provides a preview window, which allows the
operator to employ ergonomic touch and swipe
motions to adjust focus, zoom, and exposure prior to
initiating the image capture sequence. This allows
reduction of operator motion during imaging, which
can degrade image quality when using a handheld
platform (Fig. 1E). Additionally, during surveying
and focusing onto the retina the device uses far-red
LEDs that fall outside the peak photopic response of
the eye but remain within the receptive range of the
iPhone camera and filters (Fig. 1C). This approach
minimizes patient discomfort and unwanted gaze-
induced motion artifacts. Once camera positioning
and focus are optimized, the initiation of image
capture signals a high-intensity white LED to flash
during acquisition (Fig. 1D). The images can be
uploaded to a secure server directly from the app
using WiFi or cellular service for remote reviewing
(Fig. 1F).
The CellScope Retina hardware-software integra-
tion enables wide-field imaging of the retina in a
semiautomated fashion. The device is designed to
allow the operator to comfortably hold and operate
the touchscreen app using one hand (Fig. 2A). The
magnetically mounted screen displays a software-
driven target for eye fixation to minimize unwanted
eye movement during examination (Fig. 2B). This
green, 2-mm diameter fixation dot directs the non-
imaged eye to software-specified locations on the
display. Conjugate eye movements simultaneously
reposition the imaged eye for rapid and precise
imaging of multiple retinal fields (Fig. 2C). With the
current automated program, five overlapping images
are captured of the central, inferior, superior, nasal,
and temporal retina in rapid sequence (Fig. 2D and
Supplementary Movie S1). Each image has an
approximately 508 field of view and may be compu-
tationally merged with a custom algorithm that runs
directly on the smartphone to create an approximate-
ly 1008, wide-field montage of the retina (Fig. 2E).
Image-stitching could be performed either directly
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on the smartphone using custom software (Fig. 2E) or
using the DualAlign i2k software package (Clifton
Park, NY; Fig. 4). The custom on-phone algorithm
used the OpenCV Cþþ image-processing library for a
stepwise process of correcting optical distortion,
cropping the circular retinal field of view, and
estimating affine transforms between neighboring
fields using Speeded Up Robust Features (SURF)
keypoints matching. These transforms describe the
translation, rotation, and skew of each peripheral
field relative to the central field. To save on
computational resources, the transform is estimated
using downsampled grayscale images derived from
the green color channel. Finally, a full-resolution
mosaic is generated using the estimated transforms,
and overlapping regions are linearly blended.
Processing time to generate a full resolution, five-
image montage covering approximately 100 retinal
degrees (52.3 pixels/retinal degree) was approximately
5 minutes with our custom software on an iPhone 5s.
We subsequently worked with DualAlign, LLC to
generate a high-performance solution and improve
on-phone processing time. This allows a rapid
preview 1008 montage to be produced in approxi-
mately 5 seconds on an iPhone 5s using downsampled
images (6.4 pixels/retinal degree), allowing near real-
time assessment of wide-field image data. A full-
resolution montage may be generated once the
operator is satisfied with image data. Initial imple-
mentation of the i2k DualAlign library has already
pushed processing time for full resolution montage
below 50 seconds on an iPhone 5s, with further
improvements expected. All image acquisition, pro-
cessing, and review steps may be performed on the
device without requiring an external computer.
Individual images or montages may be reviewed on
the smartphone using touchscreen pinch, zoom, and
pan gestures.
Figure 2. CellScope Retina is a handheld, smartphone-based retinal camera that enables fully integrated wide-field retinal imaging. (A,
B) The device is designed for easy handheld operation. (B) A detachable display may be magnetically mounted to either side of the
device and provides a green dot as a fixation target. (C) The fixation target is translated through a series of positions, re-orienting the
patient’s eyes and retina in a rapid and controllable fashion. (D) Each individual image is approximately 508. With the current automated
arrangement, five overlapping images are captured of the central, superior, nasal, temporal, and inferior retina. (E) These five images are
computationally merged on the phone using custom software to create a wide-field image of the retina spanning approximately 1008.
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Study Participants
Study participants were recruited at the University
of Michigan Kellogg Eye Center Retina Clinic and
the Ophthalmology Consultation Service at the
University of Michigan Hospital, Ann Arbor, MI,
in accordance with the University of Michigan
Institutional Review Board, and adhered to the tenets
of the Declaration of Helsinki (ClinicalTrials.gov
Identifier NCT03076697). For feasibility testing in
DR, patients (18-years old) with diabetes and no
obvious media opacity (e.g., vitreous hemorrhage,
advanced cataract) were recruited while undergoing
routine examination in the University of Michigan
Retina Clinic. Patients in the retina clinic had a higher
prevalence of retinal disease than might be expected in
the general population. A medical student and
medical intern acquired images of DR with the
CellScope Retina. For imaging of various other
retinal abnormalities, patients over 18 years of age
were recruited by our university-based consultation
service by ophthalmology resident physicians in the
emergency room or inpatient setting. A convenience
sample of patients was enrolled from the consultation
service based on the presence of retinal abnormalities
identified from standard clinical examination. All
consenting patients underwent a gold-standard dilat-
ed eye examination as part of routine care. Partici-
pants’ demographic data, clinical findings, and
diagnoses were recorded.
Photographic and Clinical Interpretation
Patients underwent dilated fundus imaging in a
dimmed room, where CellScope Retina was used to
capture five sequential images (central, inferior,
superior, nasal, and temporal). Both eyes were imaged
unless only one eye was pharmacologically dilated for
that visit. Participants were asked to assess the
comfort level for red illumination and white flash
from CellScope Retina (‘uncomfortable’, ‘bearable’,
or ‘comfortable’), and to compare this with illumina-
tion from slit-lamp biomicroscopy. CellScope Retina
images were evaluated for the presence and severity of
diabetic retinopathy by two masked ophthalmologists
who were experienced with telemedicine grading and
following review of the modified Airlie House
classification grading criteria defined by the
ETDRS.33 These graders were masked to all patient
information and performed analysis per eye in a
randomized fashion. Each 508 image was evaluated in
a controlled environment on high-resolution (1600 3
1200 pixels) 19-inch displays with standard luminance
and contrast on a black background in accordance
with United Kingdom National Health Service
guidelines.44
A grading template was used that assessed the
quality of the image and the severity of DR. The
image quality was categorized as excellent, fair,
acceptable, or not gradable. DR severity was graded
as mild, moderate, or severe nonproliferative diabetic
retinopathy (NPDR), proliferative diabetic retinopa-
thy (PDR), or no DR in accordance with ETDRS
criteria. Because CellScope Retina acquires nonstereo
images and thus cannot determine retinal thickening,
photographic grading of clinically significant diabetic
macular edema (CSDME) was based on the presence
Figure 3. CellScope Retina produces diagnostic-quality
photographs of retinal abnormalities. (A) Hypertensive
retinopathy with ruptured RAM along the inferior arcade with
hemorrhage in multiple layers. (B) Superotemporal bullous macula-
involving rhegmatogenous retinal detachment in the right eye
extending from 9:00 to 1:00 o’clock. (C) Peripapillary myelinated
nerve fiber layer with flame-shaped appearance and feathered
borders in the left eye. (D) Circinate retinal exudates in the
inferotemporal macula of the right eye. (E) Acute papilledema with
flame hemorrhages extending from the optic disc and proximally
along the inferior arcade of the left eye. (F) DR with dot-blot and
disc hemorrhages in the right eye. (G) CMV retinitis demonstrating
broad retinal whitening along the superior arcade of the left eye.
(H) Morning Glory disc anomaly in the left eye. (I) Epiretinal
membrane with fibrovascular changes in the left eye. All images
were acquired after pharmacologic mydriasis.
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of hard exudates within 1 disc diameter of the macula
center, as previously described.46,47 Clinically, the
CSDME was defined by ETDRS criteria, including
retinal thickening within 500 lm of the macula center,
hard exudates within 500 lm of macula center with
adjacent retinal thickening, or more than 1 disc
diameter of retinal thickening partly within 1 disc
diameter of the macula center. Photographic diagno-
sis was based solely on the smartphone image
acquisition, whereas clinical diagnosis was aided by
optical coherence tomography (OCT) and included
patients actively receiving intravitreal anti-vascular
endothelial growth factor therapy or intravitreal
steroid therapy for CSDME.
The sensitivity and specificity in detection of
referral-warranted diabetic retinopathy (RWDR) is
of fundamental importance for screening programs.
RWDR was defined as equal to or greater than
Figure 4. Wide-field retinal imaging with CellScope Retina under typical and challenging imaging conditions in the inpatient setting. (A)
Retinal montage of presumed fungal endophthalmitis in a patient with a well-dilated 8.0-mm pupil who was alert and cooperative with
examination demonstrating three creamy white, well-circumscribed 500-lm lesions within 2 mm of the optic nerve. (A’) Representative
images used for retinal montage. Images A and A’ were acquired in less than 1 minute by guiding the patient’s eyes with device-assisted
fixation. (B) Retinal montage of presumed fungal endophthalmitis in a hospitalized patient with a poorly dilated 4.5-mm pupil and altered
mental status demonstrating a 16-mm large creamy white chorioretinal lesion with associated retinal hemorrhages, retinal vasculitis, and
vitritis extending from the superior arcade into the macula and threatening the fovea. (B’) Representative images demonstrating glare
and restricted retinal view as present with small pupil size. These images were acquired in approximately 4 minutes by manually
repositioning the angle of the device relative to the eye due to patient’s inability to fixate. Multi-image processing steps are employed to
improve wide-field viewing of the retina. All images were taken of bed-bound patients under normal inpatient care conditions without
additional head stabilization or repositioning. (B, B0) Image stitching was performed using the i2k DualAlign software package.
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moderate NPDR or the presence of CSDME, as
previously established.33 Traditional in-clinic diagno-
sis was considered the reference standard and
acquired retrospectively by masked chart review of
same-day visits, which had included CellScope Retina
imaging. In the event that the severity of DR was not
explicitly documented in the chart, a masked expert
reviewed the documented note, exam, and traditional
imaging studies to determine disease severity. Inter-
grader kappa and percent agreements were calculated
to assess identical grading as well as grading within
one stage. Confidence intervals (CIs) for sensitivity
and specificity were based on exact Clopper-Pearson
CIs. Statistical analysis was performed using SPSS
Statistics software (IBM, Armonk, NY). CIs for the
predictive values are the standard logit confidence
intervals given by Mercaldo et al.48
Data Availability
The datasets generated during the current study
include patient information, and may be made
available from the corresponding author on reason-
able request complying with and approved by the
relevant institutional review board committees.
Results
Device
The CellScope Retina is a hand-held, battery-
powered 3D printed optical and hardware system
built around a smartphone (Fig. 1). The retina is
imaged via a standard ophthalmic lens and relay
lenses to the cellphone camera, and the illumination
and collection optical paths feature polarization-
based rejection of reflections from intermediate
surfaces (including the cornea), as well as far-red
illumination (Fig. 1C) to increase patient comfort
during focusing steps. An external side-mounted
display (Figs. 1A, 2B) provides a moveable fixation
target to the contralateral eye to direct patient gaze
(Fig. 2C); target position may be automatically
stepped between positions during sequential imaging.
This display is magnetically affixed, allowing switch-
ing between sides for imaging either eye. Hardware
(fixation target, illumination LEDs) is controlled via
Bluetooth communication with the smartphone,
which runs a custom iPhone app allowing ergonomic
touch and swipe motions to adjust image focus, zoom,
and exposure. An automated program then collects
five overlapping retinal images (Fig. 2D), which are
computationally merged on the smartphone to create
and display an approximately 1008 montage of the
retina (Fig. 2E). Image acquisition takes approxi-
mately 1 minute for cooperative patients with
pharmacologic mydriasis. Multi-image montages
may be generated directly on the smartphone; to
our knowledge this is the first implementation of
retinal montage on-phone. Our custom software
produces full resolution 5-image montages with a
field of view of approximately 1008 (52.3 pixels/retinal
degree) in approximately 5 minutes, with image
stitching running in the background on an iPhone
5s. Initial implementation of the i2k DualAlign
library has already pushed this below 50 seconds,
with further improvements expected. Additionally,
rapid preview 1008 montage may be produced in
approximately 5 seconds on an iPhone 5s using
downsampled images (6.4 pixels/retinal degree). This
feature allows near real-time assessment of wide-field
image data during patient examination and may guide
image selection for high-resolution montage. The
software and mobile connectivity of the device allow
images to be directly uploaded to cloud-based
platforms for remote analysis or consultation.
Although the devices tested used the iPhone 5s (set
early in development to ensure consistency with our
initial clinical testing), updating to newer iPhones
involves only adaptation of the phone mounting
bracket and updating of the software—neither the
optics nor (being based on fixed LED hardware) the
ISO 15004-2:2007 safety assessment is affected.
Furthermore, the improved camera sensitivity and
processing speeds will be advantageous.
Diagnostic-Quality Imaging of Various
Retinal Pathologies
CellScope Retina captured diagnostic-quality im-
ages spanning a wide range of retinal findings. We
demonstrate several examples including hypertensive
retinopathy with a ruptured retinal arterial macro-
aneurysm (RAM) and hemorrhages, rhegmatogenous
retinal detachment, peripapillary myelinated nerve
fiber layer, circinate macular exudates, acute optic
nerve edema with disc hemorrhage, NPDR with dot-
blot and disc hemorrhages, cytomegalovirus (CMV)
retinitis, Morning Glory disc, and PDR with preret-
inal fibrovascular membrane (Fig. 3). All images were
acquired after pharmacologic mydriasis of the pupil.
The optics are designed such that the image nearly
fills the vertical dimension of the 3:4 aspect-ratio
smartphone image sensor to maximize retinal field of
view in both the vertical and horizontal dimensions.
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Images were of sufficient quality to allow rapid
diagnosis by a retinal specialist who was masked to
patients’ medical records.
Retinal Imaging in Hospital Settings
The CellScope Retina was also evaluated outside
traditional eye care facilities to assess its feasibility of
use for retinal image acquisition in the inpatient and
emergency department setting. Here, we demonstrate
wide-field retinal photography using CellScope Ret-
ina in the inpatient setting (Fig. 4). Images of two
patients with presumed fungal endophthalmitis were
taken at the bedside without either repositioning the
patient or using head stabilization devices. The first
patient was cooperative with the examination and
dilated well to 8 mm with pharmacologic mydriasis,
enabling 1008 image acquisition in less than 1 minute
using device-assisted fixation. Fundus photography
demonstrates three creamy white, well-circumscribed
500-lm lesions within 2 mm of the optic nerve (Fig.
4A). The second patient was critically ill with altered
mental status and had a poorly-dilated pupil of 4.5
mm despite pharmacologic mydriasis. Multiple imag-
es were acquired over the span of approximately 4
minutes by repositioning the angle of the device
relative to the eye due to the patient’s inability to
fixate (Fig. 4B). Under these conditions, individual
images exhibited significant glare and restricted views
of the retina (Fig. 4B’). Multi-image stitching was
employed to produce a greater than 1008 view of the
retina. Fundus photography demonstrates a 16-mm
large, creamy-white chorioretinal lesion with associ-
ated retinal hemorrhages, retinal vasculitis, and
vitritis extending from the superior arcade into the
macula and threatening the fovea (Fig. 4B).
Utility in Diabetic Retinopathy Screening
The CellScope Retina was further evaluated as a
DR screening tool to assess its ability to resolve
retinal findings in DR. We demonstrate two examples
of retinal imaging in patients with RWDR (Fig. 5).
The first patient demonstrates clear retinal abnormal-
ities including panretinal photocoagulation (PRP) in
both eyes. The right eye remains normal while the left
eye shows re-activation of PDR with preretinal
hemorrhage (Figs. 5A, 5B, respectively). The second
patient is diabetic without a known prior history of
retinopathy. Imaging with CellScope Retina in the left
eye resolves trace neovascularization and sparse
microaneurysms (Figs. 5D, 5E, respectively). Addi-
tionally, post processing of these images with red-
subtraction was employed to enhance contrast of
vascular structure within the superficial retinal layers
(Figs. 5D’, 5E’), an approach often used in traditional
fundus photography.
Pilot Testing for Diabetic Retinopathy
Screening
In order to evaluate the potential utility of
CellScope Retina for DR grading, a pilot test of 71
subjects and 142 eyes were enrolled from the
University of Michigan Kellogg Eye Center Retina
Clinic. Forty-five subjects were male, 26 were female,
and the mean age was 56.7 years (standard deviation
16.9 years). CellScope Retina imaging was performed
in 121 eyes (84%). The remaining 21 eyes were not
imaged because patients were pharmacologically
dilated in only one eye or were discharged from clinic
Figure 5. Imaging of RWDR with CellScope Retina. Fundus
photographs of a patient with diabetes mellitus with right (A)
and left (B) eye demonstrating prior PRP and re-activation of
quiescent diabetic retinopathy with preretinal hemorrhage in the
left eye. (C) Fundus photograph of the left eye in a patient with
diabetes mellitus but no known history of DR. CellScope Retina
resolves trace signs of neovascularization (D) and sparse
microaneurysms (E). Postprocessing with red-subtraction can be
used to enhance contrast of vascular structures in the superficial
retina, including neovascularization (D’) and microaneurysms (E’).
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prior to imaging both eyes. Of the 121 images
evaluated by the graders, a grade of ‘‘Excellent’’ was
given 21 times, a grade of ‘‘acceptable’’ was given 98
times, a grade of ‘‘fair’’ was given 52 times, and
‘‘ungradable’’ was given 2 times.
Detecting Referral-Warranted Diabetic
Retinopathy
The sensitivity and specificity of referral-warranted
DR detection by grader 1 were 91.4% (95% CI 83.0,
96.5), and 64.9% (95% CI 47.5, 79.8), respectively
(Table 2). The positive and negative predictive values
were 85.1% (95% CI 78.5–89.9), and 77.4% (95% CI
61.9–87.9), respectively. For grader 2, the sensitivity
and specificity for referral-warranted DR detection
were 95.1% (95% CI 88.0–98.7), and 48.7% (95% CI
31.9–65.6), respectively (Table 2). The positive and
negative predictive values were 80.4% (95% CI 74.9–
84.9), and 81.8% (95% CI 62.1–92.5), respectively.
Agreement between Image-Based Grading
and Clinical Exam
Compared with the clinical examination, for
grader 1, there was exact agreement in DR severity
grading in 57.3% of the eyes, and agreement within
one clinical stage in 88.9% of the eyes, weighted j ¼
0.63 (95% CI 0.53–0.73, Table 1). For grader 2, there
was exact agreement in 52.9% of the eyes, and
agreement within one clinical stage in 81.5% of the
eyes, weighted j ¼ 0.55 (95% CI 0.45–0.64, Table 1).
The two graders agreed perfectly 56.3% of the time
and were within one step of perfect agreement 95.0%
of the time (Fig. 6), with weighted j ¼ 0.66 (95% CI
0.57–0.74; c.f. Supplementary Table S1).
Table 1. Grader Assessments of Diabetic Retinopathy Severity of CellScope Retina Images Versus Clinical
Fundus Exam









Grader 1 0.60 (0.49, 0.71)
None 11 5 0 0 3
Mild NPDR 3 6 1 0 1
Moderate NPDR 1 6 7 1 2
Severe NPDR 0 5 10 6 10
PDR 0 1 0 1 37
Grader 2 0.50 (0.39, 0.61)
None 1 3 0 0 0
Mild NPDR 10 6 1 0 2
Moderate NPDR 3 9 12 3 9
Severe NPDR 1 4 3 3 3
PDR 0 1 2 2 41
Table 2. Grader Sensitivity and Specificity of Referral-Warranted Diabetic Retinopathy
Grader Diagnosis
Gold Standard Clinical Diagnosis
Sensitivity (95% CI) Specificity (95% CI)RWDR Non-RWDR
Grader 1
RWDR 74 13 91.4 (83.0, 96.5) 64.9 (47.5, 79.8)
Non-RWDR 7 24
Grader 2
RWDR 78 19 95.1 (88.0, 98.7) 48.7 (31.9, 65.6)
Non-RWDR 4 18
RWDR is defined as equal to or greater than moderate NPDR, or the presence of CSDME.
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Detecting Clinically Significant Diabetic
Macular Edema
For grader 1, the sensitivity and specificity for
detecting CSDME was 29.4% (95% CI 10.3–56.0) and
98.0% (95% CI 92.9–99.8). The positive and negative
predictive values were 71.4% (95% CI 34.5–92.2) and
89.0% (95% CI 85.6–91.7), respectively. For grader 2,
the sensitivity and specificity for detecting CSDME
were 68.8% (95% CI 41.3–89.0) and 83.3% (95% CI
74.4–90.2), respectively. The positive and negative
predictive values were 40.7% (95% CI 28.3–54.5) and
94.1% (95% CI 88.5–97.1), respectively (c.f. Supple-
mentary Table S2). CSDME with or without DR was
classified as referral-warranted disease. The in-clinical
diagnosis of CSDME was assisted by use of macular
OCT.
Patient Comfort
Patient comfort levels during examination with the
red illumination used to focus on the retina (Fig. 1C)
and the white flashes for image capture (Fig. 1D) were
surveyed according to a three-point scale, including
‘comfortable’, ‘bearable’, or ‘uncomfortable’. All of
the surveyed patients (Supplementary Fig. S1) report-
ed the continuous red illumination to be comfortable
throughout the examination (N¼ 87/87). Of patients,
90.8% reported the white, image-capture LED flash to
be comfortable (N ¼ 79/87), 8.0% reported the white
flash as bearable (N ¼ 7/87), and 1.1% reported the
white flash to be uncomfortable (N ¼ 1/87). Addi-
tionally, 100% of patients who also underwent slit-
lamp examination reported the CellScope Retina
illumination system to be more comfortable than the
illumination from the slit lamp (N ¼ 72/72).
Discussion
Smartphone-based retinal photography holds
great promise in ophthalmic care and telemedicine,
via leveraging of the smartphone for its portability,
low-cost, ease-of-use, high-resolution camera, and
wireless connectivity in order to capture diagnostic
retinal images. This study highlights two important
aspects of a novel, smartphone-based retinal imaging
tool, the CellScope Retina. First, CellScope Retina
was capable of capturing and stitching wide-field,
1008 images of a broad variety of retinal pathologies
in the nonoptimal imaging conditions of an ophthal-
mic consultation service and emergency department
setting. Second, the CellScope Retina achieved good
sensitivity and moderate specificity (with high inter-
grader agreement) when operated by nonophthalmic
personnel for detection of RWDR in a feasibility
study in this population. Furthermore, the portability
and ease of one-handed operation of CellScope
Retina make it possible for the device to increase
access to high-quality retinal imaging when compared
with benchtop fundus cameras.
There has been substantial effort in recent years to
incorporate smartphone-based devices in screening
and monitoring of diseases, such as glaucoma and
DR.13–15 In particular, three recent studies demon-
strate that smartphone-based retinal imaging can be
effective in screening for DR.4,16,39 Rajalakshmi et
al.4 compared grading of DR from images acquired
by the Fundus on Phone (FOP) system with
traditional benchtop fundus photography. Using the
FOP system, sensitivity and specificity for any DR
was reported as 92.7% and 98.4%, respectively, and
for sight-threatening DR (defined as proliferative DR
or CSDME) reported as 87.9% and 94.9%, respec-
tively.4 Russo et al.39 compared grading of DR from
images acquired by the D-Eye smartphone system
against clinical examination with slit-lamp biomicros-
copy. They reported exact agreement in grading of
severity of DR in 85% of cases and within one step of
agreement in 96.7%, and a sensitivity and specificity
for clinically significant macular edema as 81% and
98%, respectively.39 Toy et al.16 compared grading of
DR from images acquired by a smartphone with
macrolens adapter and external light source com-
Figure 6. Agreement in DR severity between masked reading of
CellScope Retina images and clinical examination. DR severity was
determined by two masked graders and compared with grading
from the clinical examination. For grader 1, there was exact
agreement in 57.3% of the eyes, and agreement within one step in
88.9% of the eyes (kappa coefficient was 0.63, 95% CI, 0.53–0.73).
Grader 1 was also able to detect 91.4% of RWDR as compared with
the dilated fundus examination. For grader 2, there was exact
agreement in 52.9% of the eyes, and agreement within one step in
81.5% of the eyes (kappa coefficient was 0.55, 95% CI, 0.45–0.65).
Grader 2 was also able to detect 95.1% of RWDR as compared with
the dilated fundus examination.
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pared with clinical examination. They reported that
smartphone-acquired photos demonstrated 91% sen-
sitivity and 99% specificity in detection of moderate
nonproliferative DR and worse DR.16
While these results are encouraging, the prior
literature has not addressed whether handheld retinal
photography could be made simple and intuitive for
nonexpert operators in nonideal settings. Indeed,
experience with our first generation Ocular CellScope
prototype demonstrated that smartphone imaging of
the retina, while highly possible, could also be highly
variable. The FOP system used an indirect ophthal-
moscopy arrangement with a field of view of up to 458
with mydriasis, which they reported could be used as
a handheld system or adapted to a slit-lamp frame.4
However, the FOP system has a relatively large size
and the study did not disclose who performed
photography or whether the device was mounted to
the slit lamp. Rigid stabilization of the camera and
patient’s head helps with imaging quality but is not
readily available in many community-based screening
environments. The D-Eye uses a direct ophthalmos-
copy arrangement with a field-of-view of up to 208
with mydriasis. This requires significant manual
adjustment and familiarity with retinal anatomy to
perform complete retinal imaging, and images in their
study were acquired by a retina specialist.39
Variability in image quality that could arise from
nonideal settings and nonexpert operators is a critical
consideration when screening in the community.37,38 In
order to assess this potential limitation with the
CellScope Retina, we performed a feasibility study
wherein image acquisition for grading of DR was
performed by a medical student and medicine intern
rather than ophthalmologists or ophthalmic photog-
raphers. We found that even when image acquisition
was performed by nonexpert operators, grading of
CellScope Retina images demonstrated good agree-
ment for DR and CSDME compared with clinical
examination by slit-lamp biomicroscopy, consistent
with other photographic-based methods,49 and met
British Diabetic Association guidelines for sensitivity
in screening tools used in DR.40 This was achieved, in
part, by leveraging the processing power of the phone
to simplify operational steps in image acquisition. In
particular, we focused on portable, wide-field imaging
due to the importance of peripheral retina surveillance
in diseases, such as DR. Previous studies have found
that a single 458 field of view retinal image had
relatively good detection of any DR but was inade-
quate to effectively determine severity of DR as needed
for referral.34–36 Additionally, a prospective study
using ultrawide field imaging with 200-degree field of
view (Optos plc) found that approximately one-third of
lesions (hemorrhages, microaneurysms, intraretinal
microvascular abnormalities, neovascularization) were
outside traditional ETDRS seven-field photography
(908 field of view), and 10% of patients had a more
severe grade of DR than determined by ETDRS
photography.50 These studies suggest that wider-field
surveillance of the retina may improve accuracy in
screening of DR. At the same time, cost and speed are
equally important considerations for screening in
community settings. Commercially available, handheld
systems can provide very high-quality imaging even
under nonmydriatic conditions. However, these dedi-
cated systems can cost many thousands of dollars,
require moderate training and experience to operative
reliably, and need to be paired with an external
computer to store, interpret, and transmit images.
These conditions may be prohibitive in resource limited
settings where retinal screening is most needed.
Therefore, the CellScope Retina was designed to
maximize retinal field of view while being fast, easy
to use, and inexpensive. We leverage the familiar
interface and processing power of smartphones to
simplify and automate elements of wide-field imaging
for even inexperienced operators. Images can be
stored, reviewed, and wirelessly transmitted directly
from the smartphone without an external computer.
Additionally, the processing and wireless capabilities of
smartphone-based systems hold great promise for
implementing advanced features, such as artificial
intelligence-assisted evaluation of retinal images.
This study has several important strengths. First,
masked grading of DR was performed without
providing patients’ medical history, helping to elim-
inate bias and ensuring assessment was based purely
on photographic findings. Second, nonophthalmic
operators acquired images for DR grading and, as a
result, images of lesser quality were included in
analysis and more closely simulated conditions that
may be encountered when screening in the primary
care setting. Nevertheless, CellScope Retina images
both demonstrated good agreement for DR and met
British Diabetic Association guidelines for sensitivity
of screening tools used in DR.40 Third, complex
imaging tasks, such as imaging multiple regions of the
retina for wide-field analysis, were simplified and
standardized by leveraging computational capabilities
of the phone to guide imaging. Further work in this
direction has the potential to drastically simplify and
improve the efficacy of retinal screening in the
community.
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There are several limitations to this study. First,
participants for the DR study were recruited from the
retina clinic in a tertiary care eye hospital, where the
prevalence of patient DR is much higher than in the
general population. While our feasibility study shows
promising results, additional work is required to
validate the accuracy and utility of the CellScope
Retina in the primary care and community-based
settings where the technology is most needed. Second,
CellScope Retina is currently designed as a mydriatic
device that requires patients’ eyes to be pharmaco-
logically dilated. This can be time-consuming and
uncomfortable for patients while also being unfamil-
iar to primary care physicians. Third, a medical
student and a medicine intern acquired the images for
the DR study, and additional validation for ease of
imaging would be called for if shifting to use by
medical assistants and primary care personnel.
Smartphone-based retinal imaging offers the pos-
sibility of dramatically increasing the accessibility of
ophthalmic care by remote screening and diagnosis of
vision-threatening diseases among millions of indi-
viduals not receiving regular eye examinations.
Achieving this goal will rely not only on the
familiarity and portability of smartphones, but also
on the development of novel techniques that enhance
image quality and reliability. We aimed to make wide-
field retinal imaging intuitive and reproducible for the
nonexpert operator. The resulting CellScope Retina
device harnesses hardware and software automation
controlled by a smartphone to simplify retinal
imaging, potentially improving access to ophthalmic
care through handheld and portable retinal disease
screening and diagnosis.
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